Effects of boron oxide substitution on the structure and bioactivity of SrO-containing bioactive glasses
Source abstract
Abstract
B2O3/SiO2 substitution in 55S4.3 bioactive glasses with 5 mol% of SrO has been synthesized and characterized to understand their structure and bioactivity as a function of composition by combining experimental and computer simulation techniques. Raman spectrometry, X-ray diffraction (XRD) and Fourier transform infrared spectrometry (FTIR) were utilized to characterize the structural changes induced by boron content and to identify the formation of hydroxyapatite (HAp). In vitro bioactivity tests were performed in simulated body fluid with a fixed glass mass to solution volume ratio and a particle size range. Needle-like HAp was found to form on the surface of the 55S4.3 with SrO sample from scanning electron microscopy and confirmed from XRD and FTIR. In addition to the experimental efforts, these glasses were also simulated using classical molecular dynamics simulations with partial charge potentials and recently developed parameters for boron oxide to understand their short- and medium-range structures. The glasses from simulations were analyzed in terms of the local structure around the glass network formers, especially the boron coordination number, and found to agree well with theoretical models. The medium-range structural information such as Q n distribution and network connectivity was also obtained and used to understand the compositional dependence of property and bioactivity. The results show that additional boron oxide increased the network connectivity of the 55S4.3 glass and inhibited or delayed the formation of HAp in vitro.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Dental Implant Techniques and Outcomes · Dental materials and restorations
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (73)
Show source-provided references
1. Hench LL (2006) The story of Bioglass. J Mater Sci Mater Med 17:967–97810.1007/s10856-006-0432-z ↗
2. Hench LL, Splinter RJ, Allen WC, Greenlee TK (1971) Bonding mechanisms at the interface of ceramic prosthetic materials. J Biomed Mater Res 5:117–14110.1002/jbm.820050611 ↗
3. Ogino M, Ohuchi F, Hench LL (1980) Compositional dependence of the formation of calcium phosphate films on bioglass. J Biomed Mater Res 14:55–6410.1002/jbm.820140107 ↗
4. Brink M (1997) The influence of alkali and alkaline earths on the working range for bioactive glasses. J Biomed Mater Res 36:109–11710.1002/(SICI)1097-4636(199707)36:1<109::AID-JBM13>3.0.CO;2-D ↗
5. Raju KS, Alessandri G, Ziche M, Gullino PM (1982) Ceruloplasmin, copper ions, and angiogenesis. J Natl Cancer Inst 69:1183–1188
6. Rahaman MN, Day DE, Sonny Bal B, Fu Q, Jung SB, Bonewald LF, Tomsia AP (2011) Bioactive glass in tissue engineering. Acta Biomater 7:2355–237310.1016/j.actbio.2011.03.016 ↗
7. Jones JR (2015) Reprint of: review of bioactive glass: from Hench to hybrids. Acta Biomater 23:S53–S8210.1016/j.actbio.2015.07.019 ↗
8. Bonnelye E, Chabadel A, Saltel F, Jurdic P (2008) Dual effect of strontium ranelate: stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption in vitro. Bone 42:129–13810.1016/j.bone.2007.08.043 ↗
9. Marie PJ, Hott M, Modrowski D, De Pollak C, Guillemain J, Deloffre P, Tsouderos Y (1993) An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen-deficient rats. J Bone Miner Res 8:607–61510.1002/jbmr.5650080512 ↗
10. Canalis E, Hott M, Deloffre P, Tsouderos Y, Marie PJ (1996) The divalent strontium salt S12911 enhances bone cell replication and bone formation in vitro. Bone 18:517–52310.1016/8756-3282(96)00080-4 ↗
11. Buehler J, Chappuis P, Saffar JL, Tsouderos Y, Vignery A (2001) Strontium ranelate inhibits bone resorption while maintaining bone formation in alveolar bone in monkeys (Macaca fascicularis). Bone 29:176–17910.1016/S8756-3282(01)00484-7 ↗
12. Abdelghany AM, Ouis MA, Azooz MA, ElBatal HA, El-Bassyouni GT (2016) Role of SrO on the bioactivity behavior of some ternary borate glasses and their glass ceramic derivatives. Spectrochim Acta Part A Mol Biomol Spectrosc 152:126–13310.1016/j.saa.2015.07.072 ↗
13. Fredholm YC, Karpukhina N, Brauer DS, Jones JR, Law RV, Hill RG (2011) Influence of strontium for calcium substitution in bioactive glasses on degradation, ion release and apatite formation. J R Soc Interface 9:880–88910.1098/rsif.2011.0387 ↗
14. Massera J, Hupa L (2014) Influence of SrO substitution for CaO on the properties of bioactive glass S53P4. J Mater Sci Mater Med 25:657–66810.1007/s10856-013-5120-1 ↗
15. Massera J, Kokkari A, Närhi T, Hupa L (2015) The influence of SrO and CaO in silicate and phosphate bioactive glasses on human gingival fibroblasts. J Mater Sci Mater Med 26:19610.1007/s10856-015-5528-x ↗
16. Lotfibakhshaiesh N, Brauer DS, Hill RG (2010) Bioactive glass engineered coatings for Ti6Al4V alloys: influence of strontium substitution for calcium on sintering behaviour. J Non Cryst Solids 356:2583–259010.1016/j.jnoncrysol.2010.05.017 ↗
17. Morohashi T, Sano T, Yamada S (1994) Effects of strontium on calcium metabolism in rats I. A distinction between the pharmacological and toxic doses. Jpn J Pharmacol 64:155–16210.1254/jjp.64.155 ↗
18. Grynpas MD, Marie PJ (1990) Effects of low doses of strontium on bone quality and quantity in rats. Bone 11:313–31910.1016/8756-3282(90)90086-E ↗
19. Qiu K, Zhao XJ, Wan CX, Zhao CS, Chen YW (2006) Effect of strontium ions on the growth of ROS17/2.8 cells on porous calcium polyphosphate scaffolds. Biomaterials 27:1277–128610.1016/j.biomaterials.2005.08.006 ↗
20. Tian M, Chen F, Song W, Song Y, Chen Y, Wan C, Yu X, Zhang X (2009) In vivo study of porous strontium-doped calcium polyphosphate scaffolds for bone substitute applications. J Mater Sci Mater Med 20:1505–151210.1007/s10856-009-3713-5 ↗
21. Hesaraki S, Gholami M, Vazehrad S, Shahrabi S (2010) The effect of Sr concentration on bioactivity and biocompatibility of sol–gel derived glasses based on CaO–SrO–SiO2–P2O5 quaternary system. Mater Sci Eng, C 30:383–39010.1016/j.msec.2009.12.001 ↗
22. Fu Q, Rahaman MN, Bal BS, Bonewald LF, Kuroki K, Brown RF (2010) Silicate, borosilicate, and borate bioactive glass scaffolds with controllable degradation rate for bone tissue engineering applications. II. In vitro and in vivo biological evaluation. J Biomed Mater Res Part A 95A:172–179910.1002/jbm.a.32823 ↗
23. Peddi L, Brow RK, Brown RF (2008) Bioactive borate glass coatings for titanium alloys. J Mater Sci Mater Med 19:3145–315210.1007/s10856-008-3419-0 ↗
24. RK Brow, SK Saha, JI Goldstein (1993) Interfacial reactions between titanium and borate glass. In: MRS online proceedings library archive, vol 314. p 77 (5 pages)10.1557/PROC-314-77 ↗
25. Xie K, Zhang L, Yang X, Wang X, Yang G, Zhang L, Shao H, He Y, Fu J, Gou Z (2015) Preparation and characterization of low temperature heat-treated 45S5 bioactive glass-ceramic analogues. Biomed Glasses 1:80–9210.1515/bglass-2015-0008 ↗
26. Rodriguez O, Curran DJ, Papini M, Placek LM, Wren AW, Schemitsch EH, Zalzal P, Towler MR (2016) Characterization of silica-based and borate-based, titanium-containing bioactive glasses for coating metallic implants. J Non Cryst Solids 433:95–10210.1016/j.jnoncrysol.2015.09.026 ↗
27. Huang W, Day DE, Kittiratanapiboon K, Rahaman MN (2006) Kinetics and mechanisms of the conversion of silicate (45S5), borate, and borosilicate glasses to hydroxyapatite in dilute phosphate solutions. J Mater Sci Mater Med 17:583–59610.1007/s10856-006-9220-z ↗
28. Fu Q, Rahaman MN, Fu H, Liu X (2010) Silicate, borosilicate, and borate bioactive glass scaffolds with controllable degradation rate for bone tissue engineering applications. I. Preparation and in vitro degradation. J Biomed Mater Res, Part A 95A:164–17110.1002/jbm.a.32824 ↗
29. Yao A, Wang D, Huang W, Fu Q, Rahaman MN, Day DE (2007) In vitro bioactive characteristics of borate-based glasses with controllable degradation behavior. J Am Ceram Soc 90:303–30610.1111/j.1551-2916.2006.01358.x ↗
30. Liang W, Rahaman MN, Day DE, Marion NW, Riley GC, Mao JJ (2008) Bioactive borate glass scaffold for bone tissue engineering. J Non Cryst Solids 354:1690–169610.1016/j.jnoncrysol.2007.10.003 ↗
31. Ebisawa Y, Kokubo T, Ohura K, Yamamuro T (1990) Bioactivity of CaO·SiO2-based glasses:in vitro evaluation. J Mater Sci Mater Med 1:239–24410.1007/BF00701083 ↗
32. Manupriya, Thind KS, Sharma G, Singh K, Rajendran V, Aravindan S (2007) Soluble borate glasses. In vitro analysis. J Am Ceram Soc 90:467–47110.1111/j.1551-2916.2006.01449.x ↗
33. Hill R (1996) An alternative view of the degradation of bioglass. J Mater Sci Lett 15:1122–112510.1007/BF00539955 ↗
34. Lopes PP, Ferreira BJML, Gomes PS, Correia RN, Fernandes MH, Fernandes MHV (2011) Silicate and borate glasses as composite fillers: a bioactivity and biocompatibility study. J Mater Sci Mater Med 22:1501–151010.1007/s10856-011-4331-6 ↗
35. Marquardt LM, Day D, Sakiyama-Elbert SE, Harkins AB (2014) Effects of borate-based bioactive glass on neuron viability and neurite extension. J Biomed Mater Res Part A 102:2767–277510.1002/jbm.a.34944 ↗
36. Modglin VC, Brown RF, Jung SB, Day DE (2013) Cytotoxicity assessment of modified bioactive glasses with MLO-A5 osteogenic cells in vitro. J Mater Sci Mater Med 24:1191–119910.1007/s10856-013-4875-8 ↗
37. J Du (2015) Challenges in molecular dynamics simulations of multicomponent oxide glasses. In: Molecular dynamics simulations of disordered materials: from network glasses to phase-change memory alloys. Springer series in material science, vol 215. Springer, pp 157–17710.1007/978-3-319-15675-0_7 ↗
38. Xiang Y, Du J (2011) Effect of strontium substitution on the structure of 45S5 bioglasses. Chem Mater 23:2703–271710.1021/cm102889q ↗
39. Du J, Xiang Y (2016) Investigating the structure–diffusion–bioactivity relationship of strontium containing bioactive glasses using molecular dynamics based computer simulations. J Non-Cryst Solids 432:35–4010.1016/j.jnoncrysol.2015.03.015 ↗
40. Du J, Xiang Y (2012) Effect of strontium substitution on the structure, ionic diffusion and dynamic properties of 45S5 bioactive glasses. J Non Cryst Solids 358:1059–107110.1016/j.jnoncrysol.2011.12.114 ↗
41. Xiang Y, Du J, Skinner LB, Benmore CJ, Wren AW, Boyd DJ, Towler MR (2013) Structure and diffusion of ZnO–SrO–CaO–Na2O–SiO2 bioactive glasses: a combined high energy X-ray diffraction and molecular dynamics simulations study. RSC Adv 3:5966–597810.1039/c3ra23231j ↗
42. Bonhomme C, Gervais C, Folliet N, Pourpoint F, Coelho Diogo C, Lao J, Jallot E, Lacroix J, Nedelec J, Iuga D, Hanna JV, Smith ME, Xiang Y, Du J, Laurencin D (2012) 87Sr solid-state NMR as a structurally sensitive tool for the investigation of materials: antiosteoporotic pharmaceuticals and bioactive glasses. J Am Chem Soc 134:12611–1262810.1021/ja303505g ↗
43. Tilocca A, Cormack AN (2009) Modeling the water–bioglass interface by ab initio molecular dynamics simulations. ACS Appl Mater Interfaces 1:1324–133310.1021/am900198t ↗
44. Deng L, Du J (2016) Development of effective empirical potentials for molecular dynamics simulations of the structures and properties and boroaluminosilicate glasses. J Non Cryst Solids 453:177–19410.1016/j.jnoncrysol.2016.09.021 ↗
45. Macon AL, Kim TB, Valliant EM, Goetschius K, Brow RK, Day DE, Hoppe A, Boccaccini AR, Kim IY, Ohtsuki C, Kokubo T, Osaka A, Vallet-Regi M, Arcos D, Fraile L, Salinas AJ, Teixeira AV, Vueva Y, Almeida RM, Miola M, Vitale-Brovarone C, Verne E, Holand W, Jones JR (2015) A unified in vitro evaluation for apatite-forming ability of bioactive glasses and their variants. J Mater Sci Mater Med 26:11510.1007/s10856-015-5403-9 ↗
46. Kokubo T, Takadama H (2006) How useful is SBF in predicting in vivo bone bioactivity? Biomaterials 27:2907–291510.1016/j.biomaterials.2006.01.017 ↗
47. Todorov IT, Smith W, Trachenko K, Dove MT (2006) DL_POLY_3: new dimensions in molecular dynamics simulations via massive parallelism. J Mater Chem 16:1911–191810.1039/b517931a ↗
48. L Deng, J Du, unpublished data
49. Dell WJ, Bray PJ, Xiao SZ (1983) 11B NMR studies and structural modeling of Na2O–B2O3–SiO2 glasses of high soda content. J Non Cryst Solids 58:1–1610.1016/0022-3093(83)90097-2 ↗
50. Yun YH, Bray PJ (1978) Nuclear magnetic resonance studies of the glasses in the system Na2O–B2O3–SiO2. J Non Cryst Solids 27:363–38010.1016/0022-3093(78)90020-0 ↗
51. Du L, Stebbins JF (2005) Network connectivity in aluminoborosilicate glasses: a high-resolution 11B, 27Al and 17O NMR study. J Non Cryst Solids 351:3508–352010.1016/j.jnoncrysol.2005.08.033 ↗
52. Fredholm YC, Karpukhina N, Law RV, Hill RG (2010) Strontium containing bioactive glasses: glass structure and physical properties. J Non Cryst Solids 356:2546–255110.1016/j.jnoncrysol.2010.06.078 ↗
53. Tilocca A (2008) Short-and medium-range structure of multicomponent bioactive glasses and melts: an assessment of the performances of shell-model and rigid-ion potentials. J Chem Phys 129:08450410.1063/1.2972146 ↗
54. Aguiar H, Solla EL, Serra J, González P, León B, Malz F, Jäger C (2008) Raman and NMR study of bioactive Na2O–MgO–CaO–P2O5–SiO2 glasses. J Non Cryst Solids 354:5004–500810.1016/j.jnoncrysol.2008.07.033 ↗
55. Lin C, Chen S, Leung KS, Shen P (2012) Effects of CaO/P2O5 ratio on the structure and elastic properties of SiO2–CaO–Na2O–P2O5 bioglasses. J Mater Sci Mater Med 23:245–25810.1007/s10856-011-4504-3 ↗
56. Agathopoulos S, Tulyaganov DU, Ventura JMG, Kannan S, Karakassides MA, Ferreira JMF (2006) Formation of hydroxyapatite onto glasses of the CaO–MgO–SiO2 system with B2O3, Na2O, CaF2 and P2O5 additives. Biomaterials 27:1832–184010.1016/j.biomaterials.2005.10.033 ↗
57. Zhang XH, Yue YL, Wu HT (2013) Effects of cation field strength on structure and properties of boroaluminosilicate glasses. Mater Res Innovations 17:212–21710.1179/1433075X12Y.0000000051 ↗
58. Serra J, González P, Liste S, Serra C, Chiussi S, León B, Pérez-Amor M, Ylänen HO, Hupa M (2003) FTIR and XPS studies of bioactive silica based glasses. J Non Cryst Solids 332:20–2710.1016/j.jnoncrysol.2003.09.013 ↗
59. Aguiar H, Serra J, González P, León B (2009) Structural study of sol–gel silicate glasses by IR and Raman spectroscopies. J Non Cryst Solids 355:475–48010.1016/j.jnoncrysol.2009.01.010 ↗
60. Peitl Filho O, Latorre GP, Hench L (1996) Effect of crystallization on apatite-layer formation of bioactive glass 45%. J Biomed Mater Res 30:509–51410.1002/(SICI)1097-4636(199604)30:4<509::AID-JBM9>3.0.CO;2-T ↗
61. Hench LL, Wilson J (1993) An introduction to bioceramics. World Scientific Publishing Co., Singapore, p 38610.1142/2028 ↗
62. Zadpoor AA (2014) Relationship between in vitro apatite-forming ability measured using simulated body fluid and in vivo bioactivity of biomaterials. Mater Sci Eng C 35:134–14310.1016/j.msec.2013.10.026 ↗
63. Varila L, Fagerlund S, Lehtonen T, Tuominen J, Hupa L (2012) Surface reactions of bioactive glasses in buffered solutions. J Eur Ceram Soc 32:2757–276310.1016/j.jeurceramsoc.2012.01.025 ↗
64. Jones JR, Sepulveda P, Hench LL (2001) Dose-dependent behavior of bioactive glass dissolution. J Biomed Mater Res 58:720–72610.1002/jbm.10053 ↗
65. McGrail BP, Ebert WL, Bakel AJ, Peeler DK (1997) Measurement of kinetic rate law parameters on a Na–Ca–Al borosilicate glass for low-activity waste. J Nucl Mater 249:175–18910.1016/S0022-3115(97)00213-4 ↗
66. Lebecq I, Désanglois F, Leriche A, Follet-Houttemane C (2007) Compositional dependence on the in vitro bioactivity of invert or conventional bioglasses in the Si–Ca–Na–P system. J Biomed Mater Res, Part A 83A:156–16810.1002/jbm.a.31228 ↗
67. Brink M, Turunen T, Happonen R, Yli-Urpo A (1997) Compositional dependence of bioactivity of glasses in the system Na2O–K2O–MgO–CaO–B2O3–P2O5–SiO2. J Biomed Mater Res 37:114–12110.1002/(SICI)1097-4636(199710)37:1<114::AID-JBM14>3.0.CO;2-G ↗
68. Manupriya, Thind KS, Singh K, Kumar V, Sharma G, Singh DP, Singh D (2009) Compositional dependence of in vitro bioactivity in sodium calcium borate glasses. J Phys Chem Solids 70:1137–114110.1016/j.jpcs.2009.05.025 ↗
69. Saranti A, Koutselas I, Karakassides MA (2006) Bioactive glasses in the system CaO–B2O3–P2O5: preparation, structural study and in vitro evaluation. J Non Cryst Solids 352:390–39810.1016/j.jnoncrysol.2006.01.042 ↗
70. Brauer DS, Karpukhina N, O’Donnell MD, Law RV, Hill RG (2010) Fluoride-containing bioactive glasses: effect of glass design and structure on degradation, pH and apatite formation in simulated body fluid. Acta Biomater 6:3275–328210.1016/j.actbio.2010.01.043 ↗
71. Cai S, Xu GH, Yu XZ, Zhang WJ, Xiao ZY, Yao KD (2009) Fabrication and biological characteristics of beta-tricalcium phosphate porous ceramic scaffolds reinforced with calcium phosphate glass. J Mater Sci Mater Med 20:351–35810.1007/s10856-008-3591-2 ↗
72. Brauer DS (2015) Bioactive glasses—structure and properties. Angew Chem Int Ed 54:4160–418110.1002/anie.201405310 ↗
73. Edén M (2011) The split network analysis for exploring composition–structure correlations in multi-component glasses: I. Rationalizing bioactivity-composition trends of bioglasses. J Non Cryst Solids 357:1595–160210.1016/j.jnoncrysol.2010.11.098 ↗